Novartis (NVS) offers a compelling value opportunity with EPS growth, margin expansion, and a robust pipeline at a discounted ...

Water infrastructure products manufacturer Mueller Water Products reported Q4 CY2025 results , with sales up 4.6% year on ...

Discover why Altria is still a buy: 6.8% dividend, discounted valuation, FDA-approved nicotine pouches, and $85.40 bull ...

Sampo plc, financial statement release, 5 February 2026 at 8:30 am EET Sampo Group's results for 2025 Like-for-like top-line growth came in at 8 per cent on the back of strong performance across ...

Outerwear manufacturer Columbia Sportswear (NASDAQ:COLM) reported Q4 CY2025 results , but sales fell by 2.4% year on year to ...

Are you scared to invest in the stock market? Well, if you do, know that you are not alone! There’s so much financial jargon and math to take in. You can confidently make well-informed investment ...

Since 1957, this metric has, with 100% accuracy, foreshadowed short-term directional moves in the stock market's benchmark ...

Pathward Financial, Inc. (NASDAQ:CASH) Q1 2026 Earnings Call Transcript January 22, 2026 Pathward Financial, Inc. beats ...

Ad hoc Announcement pursuant to Art. 53 Listing Rules of SIX Swiss Exchange Zurich, Switzerland, January 29, 2026Q4 2025 results Strong Q4 orders, improved operational performance with good cash flow ...

Pfizer, Inc. Common Stock is expected* to report earnings on 02/03/2026 before market open. The report will be for the fiscal Quarter ending Dec 2025. According to Zacks Investment Research, based on ...